There is circumstantial evidence from historic trials. See Post #:57675059 by @Mason14.
See also the following. The two patients described here are still alive and they were treated in 1980s and 1990s respectively.
https://www.raceoncology.com/wp-content/uploads/2020/08/PBC-060818-Bisantrene-Combo-Poster.pdf
The drug was previously approved in France at higher dosage than the dose that will be used for inhibiting FTO. This lower chance of side-effects due to the lower dosage.
There is circumstantial evidence from historic trials. See Post...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.010(0.65%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.56 | $1.51 | $95.69K | 62.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3015 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 4018 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |